A detailed history of Wasatch Advisors Inc transactions in Immatics N.V. stock. As of the latest transaction made, Wasatch Advisors Inc holds 872,511 shares of IMTX stock, worth $6.19 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
872,511
Previous 843,272 3.47%
Holding current value
$6.19 Million
Previous $9.8 Million 1.6%
% of portfolio
0.05%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.93 - $12.92 $319,582 - $377,767
29,239 Added 3.47%
872,511 $9.96 Million
Q2 2024

Aug 14, 2024

BUY
$9.78 - $13.49 $1.1 Million - $1.52 Million
112,878 Added 15.45%
843,272 $9.8 Million
Q1 2024

Apr 18, 2024

BUY
$10.23 - $12.94 $7.47 Million - $9.45 Million
730,394 New
730,394 $7.68 Million

Others Institutions Holding IMTX

About Immatics N.V.


  • Ticker IMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,227,000
  • Market Cap $541M
  • Description
  • Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...
More about IMTX
Track This Portfolio

Track Wasatch Advisors Inc Portfolio

Follow Wasatch Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.